Printer Friendly
The Free Library
14,680,088 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Generic drugs topic

Statistics subtopic

 

Articles

1-14 out of 14 article(s)
Title Author Type Date Words
Prescription Solutions' Generic Usage Rates Surpass All-Time Industry Highs, According to New Study. Dec 10, 2009 571
Just when you thought things might be getting better for the GOP, Gallup delivers some bad news: Among independent voters, Republicans are leading Democrats on the generic congressional ballot by 22 percent. Brief article Dec 7, 2009 91
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Potential - Analyse Forecasts Up To 2018. Oct 28, 2009 408
SDI Reports: Promotional Expenditures Flatten as the Number of Branded Blockbuster Drugs Decreases. May 11, 2009 467
High Growth Reported for The Cardiovascular Market: Competitive landscape, global market analysis and pipeline analysis. Industry overview Feb 10, 2009 2666
European CMO Markets Spurred by Rise in the Number of Biologicals. May 27, 2008 648
Consumers' Average Prescription Drug Copay Drops as Generic Drug Use Grows. Apr 16, 2008 738
Emerging Generic Drug Markets in Europe is a Comparative Study of High Growth Markets of Opportunity. Dec 19, 2007 844
Research and Markets: Apotex Generics Company Intelligence Report Brings You the New up to Date Developments within This Generics Company. Report Aug 7, 2007 375
Research and Markets: Gain an Insight into Mayne Pharma, One of the World's Leading Generic Injectable Drug Manufacturers. May 24, 2007 585
Research and Markets: KRKA Generics Company Report Is Packed With Facts, Figures And Statistics, Providing You With The Most Thorough Ongoing Monitoring Of The Company. May 22, 2007 286
Research and Markets: KRKA Generics Company Report is Packed with Facts, Figures and Statistics, Providing You with the Most Thorough Ongoing Monitoring of the Company. Nov 27, 2006 286
Healthcare Spending in Switzerland Accounts for 11.1% of GDP, with per capita Spending the Second Highest in the World after the USA: Switzerland Generics Market Intelligence Report. Jun 21, 2006 408
Foley & Lardner Survey of Industry Insiders Reflects Desire for European Regulatory Approach to Follow-on Biologics; Despite Current Gridlock, 50 Percent of Respondents Believe the FDA Has the Authority to Approve Follow-on Biologics. Jun 13, 2006 841

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles